TELO Telomir Pharmaceuticals, Inc.: Total Stockholders' Equity

Telomir Pharmaceuticals (TELO) is a young life-extension research firm where management is still being streamlined and executives are prioritizing science over commercialization. This price chart confirms a real-time valuation of 0.01. The company is developing telomere regeneration agents to slow down biological aging. Management is currently adapting internal processes while awaiting the verdict on initial tests.

TELO - Telomir Pharmaceuticals Corp Book Capitalization over the range 02/21/2024 - 10/30/2026

TELO (Telomir Pharmaceuticals, Inc.): analytical breakdowns and indicator data

- share price and expert price forecast:

Price Chart Telomir Pharmaceuticals Corp|TELO - Price Target Chart

- company stock capitalization data:

Market Value Telomir Pharmaceuticals Inc|TELO - Total Company Value

- company book value details:

Share Book Value Telomir Pharmaceuticals|TELO - Book Capitalization|Market Value to Book Value telomirpharma.com|TELO - Company Total Assets

- debt and liquidity data:

Total Debt to Capital Telomir Pharmaceuticals|TELO - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital Telomir Pharmaceuticals Inc|TELO - Company Debts|Debt to Book Value Telomir Pharmaceuticals Inc|TELO - Company Long-Term Debts|Company Short-Term Debts Telomir Pharmaceuticals|Intermediate Coverage Ratio telomirpharma.com

- earnings and market ratios statistics:

TELO - Company Net Income

Initial company analysis:Telomir Pharmaceuticals

Mass-produced product of Telomir Pharmaceuticals Inc

Book value capitalization reflects the actual value of the issuer's net assets after deducting all debt obligations, allowing for an assessment of the business's intrinsic value regardless of market fluctuations. By analyzing the trend of the company's equity on the balance sheet, an investor can see the resilience of Telomir Pharmaceuticals (TELO), whose biotechnological developments create a defensive asset isolated from global macroeconomic shocks and recessions.

Competitor analysis for Telomir Pharmaceuticals

HLN: Company Book Value|Kenvue Inc. (KVUE) - Company Book Value|Total Stockholders' Equity veronapharma.com (VRNA)|Company Book Value Jyong Biotech|Ligand Pharmaceuticals Incorporated - Net Asset Value|Book Capitalization AMRX|PRGO (Perrigo Corp) - Accounting Value of Company|Book Capitalization ALVO (Alvotech)|Book Capitalization liquidia.com LQDA|GLPG - Company Book Value|Accounting Value of Company ANIP (ANI Pharmaceuticals Inc)|MannKind Corp. (MNKD) - Company Book Value|Company Net Assets Amphastar Corp|PCRX (Pacira BioSciences) - Book Capitalization|Book Capitalization ars-pharma.com|Company Net Assets TBPH (Theravance Biopharma, Inc.)|AQST (Aquestive Therapeutics Inc) - Accounting Value of Company|Company Book Value scPharmaceuticals SCPH|Tectonic Therapeutic Inc. (TECX) - Total Stockholders' Equity|TNXP: Company Net Assets|China SXT Pharmaceuticals - Total Net Assets|EPRX: Book Capitalization|BioHarvest Sciences, Inc. - Accounting Value of Company|EXOZ (Invizyne Technologies, Inc.) - Book Capitalization|Total Stockholders' Equity Oramed Pharma ORMP|Company Book Value Entera Bio Ltd. (ENTX)|HYFT (ipatherapeutics.com) - Accounting Value of Company|ABVC BioPharma, Inc. - Company Net Assets|Total Net Assets CPIX (Cumberland Pharmaceuticals Inc)|Quantum BioPharma Limited - Book Capitalization|Total Stockholders' Equity FibroGen Corporation|ranitherapeutics.com (RANI) - Company Book Value|SNYR (Synergy CHC) - Company Book Value|Company Book Value Rallybio Corp|Total Stockholders' Equity Lexaria LEXX|Company Book Value Pulmatrix Corp (PULM)|Company Net Assets ftzy.com.cn PTHL|Book Capitalization APM (Aptorum Group)|Book Valuation of Business lyratherapeutics.com (LYRA)|IBO - Company Book Value|Accounting Value of Company TNFA (TNF Pharmaceuticals)|YCBD (cbdmd.com) - Company Net Assets|PainReform Corp - Accounting Value of Company|Company Book Value Altamira Therapeutics Ltd|lipella.com - Net Asset Value|Book Capitalization OPTN|PIRS (Pieris Pharmaceuticals Inc) - Accounting Value of Company|Book Capitalization PROC (Procaps Group SA)|Book Capitalization Petros Pharma PTPI|QLI - Company Book Value|Accounting Value of Company SLRN (acelyrin.com)|TFF Pharmaceuticals, Inc. (TFFP) - Company Book Value